Quinta-Analytica s.r.o.

Prague 44 trials 1 recruiting

44 Registered trials

1 Currently recruiting

Organisation

Quinta-Analytica s.r.o.

Location

Prague, Czechia

Identifier

ORG-100011570

Address

Umelecka 305/1, Moravska Ostrava, 702 00, Czechia

Departments

Clinic
clinical
Clinical Unit
Clinical Unit of Quinta-Analytica s.r.o
Klinika onkologie a radioterapie
management
N/A
Quinta-Analytica

Clinical trials at this site (44)

Search interface

A study comparing different dosage forms of midazolam and how they are taken up in the body. Pending

2025-524999-37-00 Bioavailability Study under Fasting Conditions 3
Randomized, open-label, multiple dose, two-period, two-treatment, cross-over pharmacodynamic study in healthy male and female participants u… Pending

2026-526556-31-00 Pharmacodynamic study under fasting condition. 3
To evaluate the pharmacokinetics and safety of nolasiban Recruiting

2025-523706-32-00 not applicable (submitted trial is a pharmacokinetic st 3 2026-02-17
Multiple-dose, open-label, laboratory blinded, randomized, 2-period, 2-sequence, crossover, steady-state bioequivalence study comparing the … Ended

2026-526102-33-00 No medical condition 2 2026-05-11
Bioequivalence Study of Empagliflozin Ended

2026-525434-33-00 Not applicable (submitted trial is a BE study in health 2 2026-04-07
The pilot bioavailability study comparing the absorption of carbetocin (which is used as prevention of heavy bleeding after childbirth) in P… Ended

2025-524768-39-00 Not applicable (submitted trial is a bioavalability stu 2 2026-03-13
Randomized, open-label, laboratory-blinded, balanced, single dose, 3-treatment, 6-sequence, 3-period crossover comparative bioavailability s… Ended

2026-525256-29-00 Comparative bioavailability study under fasting conditi 3 2026-03-13
Single dose, open-label, laboratory blinded, randomized, 2-treatment, 2-period, 2-sequence, crossover, pivotal study to assess the relative … Ended

2025-521732-11-00 No medical condition 2 2026-03-09
Study to compare drug availability in the bloodstream of two oral formulations of dexketoprofen in healthy volunteers under fasting conditio… Ended

2025-524061-24-01 Bioequivalence clinical trial in healthy volunteers und 2 2026-02-13
Single dose, open-label, laboratory blinded, randomized, 2-treatment, 2-period, 2-sequence, crossover, pivotal study to assess the relative … Ended

2025-524035-39-00 Bioavailability study in healthy volunteers under fasti 2 2026-01-14
Single-center, single-dose, open-label, laboratory-blinded, randomized, two-treatment, two-period bioequivalence (BE) study comparing the Te… Ended

2025-523137-25-00 Comparative bioequivalence study in healthy volunteers 2 2025-11-03
Open-label, randomized, two-period, two-treatment, two-sequence, crossover, balanced, study to assess the bioequivalence between the test pr… Ended

2025-522971-27-00 Bioequivalence study under fasting conditions 2 2025-10-20
The pivotal bioequivalence study comparing the test product to the reference product, which belongs to the group of medicines used in treatm… Ended

2025-523325-18-00 Bioequivalence study under fasting conditions 2 2025-10-15
A randomised, open label, three periods, three-treatment crossover study to evaluate the pharmacokinetics of alendronic acid oral formulatio… Ended

2025-522606-20-00 Pharmacokinetic study in healthy volunteers under faste 3 2025-10-06
Single dose, open-label, laboratory blinded, randomized, 2-treatment, 2-period, 2-sequence, crossover, pivotal study to assess the comparati… Ended

2025-522254-39-00 Bioavailability study in healthy volunteers under fed c 3 2025-09-29
The pivotal bioequivalence study comparing the test product to the reference product, which belong to the group of medicines used in the tre… Ended

2025-522975-27-00 Not applicable (submitted trial is a BE study in health 2 2025-09-29
Randomized, open-label, replicated single-dose, 4-period, 2-sequence crossover study to assess the comparative bioavailability of test produ… Ended

2025-523054-14-00 not applicable (submitted trial is bioavailability) 2 2025-09-15
The pivotal bioequivalence study comparing the test product to the reference product, which belongs to the group of medicines used in treatm… Ended

2025-522976-10-00 Not applicable (submitted trial is a BE study in health 2 2025-09-10
The bioavailability study of Dapagliflozin Ended

2025-522234-31-00 not applicable (submitted trial is a bioequivalence stu 2 2025-08-20
Pharmacokinetic study of colistimethate sodium Ended

2024-520019-41-00 serious infections caused by selected aerobic gram-nega 3 2025-06-30
A Phase 1, Open-Label, 2-Period, 2-Formulation, Within-Subject Crossover Comparative Pharmacokinetic, Pharmacodynamic, and Safety Study of 1… Ended

2025-521615-39-00 not applicable (submitted trial is a pharmacokinetic an 3 2025-06-04
The pivotal bioequivalence study comparing the test product to the reference product, which belongs to the group of medicines used in treatm… Ended

2025-521400-21-00 Not applicable (submitted trial is a BE study in health 2 2025-05-15
The pivotal bioequivalence study comparing the test product to the reference product, which belong to the group of medicines used in treatme… Ended

2024-518988-35-00 Not applicable (submitted trial is a bioequivalence in 2 2025-04-01
A randomised, open label, single dose, two periods, crossover study of the comparative pharmacokinetics of two alendronic acid formulations … Ended

2024-519666-43-00 not applicable (submitted trial is a pharmacokinetic st 3 2025-03-04